The Doctoral Network CAARE - “Characterization and Recovery of Bionanoparticles for Vaccine Delivery and Gene Therapy” focuses on a rapidly emerging field in biopharmaceutical industry and a new class of molecules, the bionanoparticles. Bionanoparticles are currently used as conventional vaccines, mRNA vaccines or gene therapy. In CAARE we will develop new and intensified downstream processes and analytical tools, which are essential to obtain a pure therapeutic product and to ensure the efficacy and safety of the therapy. We have have formed a consortium to train 14 doctoral candidates with beyond state-of-the art bioprocess and analytical skills directed for bionanoparticle purification.
This project has received funding from the European Union‘s Horizon Europe research and innovation program under the Marie Skłodowska Curie grant agreement No. 101168862.
Company Details
- Employees
- 2
- Address
- Karlsruhe
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.caare-project.eu
Caare - Doctoral Network Questions
Caare - Doctoral Network's website is https://www.caare-project.eu
Caare - Doctoral Network's LinkedIn profile is https://www.linkedin.com/company/caare-dn
Caare - Doctoral Network has
2 employees.
View email and phone details for 2
employees at Caare - Doctoral Network.
Caare - Doctoral Network's industry is
Pharmaceutical Manufacturing
Caare - Doctoral Network's top competitors are
Abs Biotechnologies Gmbh,
Tridem Bioscience,
Bio-Pat E.v.,
Velalabs,
Ibet - Instituto De Biologia Experimental E Tecnológica,
Valanx Biotech,
Icosagen,
Sarcura,
Oncoone,
Acib Gmbh.
Caare - Doctoral Network's categories are Pharmaceutical Manufacturing
